title: Pulmonary hypertension and pregnancy: an overview.
abstract: Pulmonary hypertension is a syndrome infrequently associated with pregnancy. Despite advancements in therapy during the past 25 years and encouraging reports of improved outcomes, pulmonary arterial hypertension remains a devastating disease with a significantly reduced lifespan. This disorder should still be considered a contraindication to pregnancy. The decision of a patient to continue the pregnancy should be supported by an empathetic group of health care professionals who would optimize their treatment and hopefully their pregnancy outcomes and survival after delivery. We overview here different aspects of the diagnosis, evaluation, management, and counseling of patients suffering from pulmonary hypertension during pregnancy.
authors.affiliation: *Department of Obstetrics, Gynecology and Reproductive Medicine, Division of Maternal-Fetal Medicine, University of Texas Health Science Center, Houston, Texas †Complejo Hospitalario, Caja de Seguro Social, Panama City, Panama.
authors.forename: Alfredo
authors.initials: A
authors.lastname: Gei
authors.forename: Carlos
authors.initials: C
authors.lastname: Montúfar-Rueda
mesh_terms: D000773:Anesthesia, Obstetrical / Q000379:methods*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002585:Cesarean Section / Q000379:methods*; D019468:Disease Management; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000628:therapy*; D016040:Lung Transplantation; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use*; D011181:Postnatal Care; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis / Q000628:therapy*; D044062:Prostaglandins I / Q000627:therapeutic use*
chemical_list: D002121:Calcium Channel Blockers; D058986:Phosphodiesterase 5 Inhibitors; D044062:Prostaglandins I